Charles Explorer logo
🇬🇧

Sitagliptin may reduce mortality in type 2 diabetics hospitalized for COVID-19

Publication at Second Faculty of Medicine |
2021

Abstract

Summary with commentary. Citation: Solerte SB, et al.

Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, case-control, retrospective, observational study. Diabetes care. 2020 Dec; 43 (12): 2999-3006.